在VEGF诱受体可溶性Fms-like氨酸激酶1与巨细胞结合
Cleo C L van Aanhold1, Qing Yong1, Lisa Landman1
1Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Angiogenesis
|May 2, 2025
概括
可溶性Fms类氨酸激酶-1 (sFLT1) 与巨细胞直接相互作用,影响它们的炎症反应. 这种相互作用,特别是在替代激活过程中,表明sFLT1在控制抗炎性巨细胞功能方面发挥了新的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 可溶性Fms类铁酶-1 (sFLT1) 是已知的血管内皮生长因子 (VEGF) 抑制剂,主要以其抗血管性质而闻名.
- sFLT1还表现出抗炎和组织修复作用,之前的研究表明它可以改善纤维化,并减少糖尿病病中的巨细胞透.
- 通过sFLT1调节炎症的精确机制,特别是它与免疫细胞的相互作用,仍然不完全理解.
研究的目的:
- 调查sFLT1是否与巨细胞直接相互作用.
- 为了阐明sFLT1如何通过细胞表面相互作用调节巨细胞炎症.
主要方法:
- 使用流式细胞计量检测sFLT1与巨细胞系 (THP-1,RAW264.7) 和初级巨细胞结合.
- 采用酶研究,质谱和RNA测序来识别sFLT1相互作用体和受sFLT1.1影响的信号通路.
- 研究了肝硫酸盐和神经活素-1在sFLT1结合中的作用.
主要成果:
- 在实验室中证明了sFLT1与各种巨细胞类型的直接结合.
- 观察到,IL-4诱导的替代激活显著增加sFLT1结合,而IFN-γ/LPS诱导的炎症主导激活则降低了它.
- 证实 sFLT1 的结合依赖于肝素硫酸盐,并与神经平素-1 结合,导致化学因子受体的表达减少.
结论:
- sFLT1直接与巨细胞相互作用,将其已知的功能扩展到血管生成之外.
- 巨细胞极化状态,特别是IL-4的替代激活,强烈影响sFLT1细胞表面的结合,可能是通过神经平素-1.
- 这些发现揭示了sFLT1在直接调节抗炎巨细胞功能的新机制,提供了新的治疗途径.
更多相关视频
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


